Literature DB >> 18811140

Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.

James C Barrow1, Shaun R Stauffer, Kenneth E Rittle, Phung L Ngo, ZhiQiang Yang, Harold G Selnick, Samuel L Graham, Sanjeev Munshi, Georgia B McGaughey, M Katharine Holloway, Adam J Simon, Eric A Price, Sethu Sankaranarayanan, Dennis Colussi, Katherine Tugusheva, Ming-Tain Lai, Amy S Espeseth, Min Xu, Qian Huang, Abigail Wolfe, Beth Pietrak, Paul Zuck, Dorothy A Levorse, Daria Hazuda, Joseph P Vacca.   

Abstract

A high-throughput screen at 100 microM inhibitor concentration for the BACE-1 enzyme revealed a novel spiropiperidine iminohydantoin aspartyl protease inhibitor template. An X-ray cocrystal structure with BACE-1 revealed a novel mode of binding whereby the inhibitor interacts with the catalytic aspartates via bridging water molecules. Using the crystal structure as a guide, potent compounds with good brain penetration were designed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18811140     DOI: 10.1021/jm800914n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

Review 1.  Chemistry and biology of multicomponent reactions.

Authors:  Alexander Dömling; Wei Wang; Kan Wang
Journal:  Chem Rev       Date:  2012-03-22       Impact factor: 60.622

2.  Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease.

Authors:  Xueli Zhang; Yanli Tian; Can Zhang; Xiaoyu Tian; Alana W Ross; Robert D Moir; Hongbin Sun; Rudolph E Tanzi; Anna Moore; Chongzhao Ran
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-21       Impact factor: 11.205

3.  Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.

Authors:  Vladimir Volloch; Bjorn Olsen; Sophia Rits
Journal:  Ann Integr Mol Med       Date:  2020

4.  Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.

Authors:  Vladimir Volloch; Bjorn R Olsen; Sophia Rits
Journal:  Ann Integr Mol Med       Date:  2019-11-20

5.  Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor that Affords Robust CNS Aβ Reduction.

Authors:  Andrew W Stamford; Jack D Scott; Sarah W Li; Suresh Babu; Dawit Tadesse; Rachael Hunter; Yusheng Wu; Jeffrey Misiaszek; Jared N Cumming; Eric J Gilbert; Chunli Huang; Brian A McKittrick; Liwu Hong; Tao Guo; Zhaoning Zhu; Corey Strickland; Peter Orth; Johannes H Voigt; Matthew E Kennedy; Xia Chen; Reshma Kuvelkar; Robert Hodgson; Lynn A Hyde; Kathleen Cox; Leonard Favreau; Eric M Parker; William J Greenlee
Journal:  ACS Med Chem Lett       Date:  2012-07-12       Impact factor: 4.345

6.  Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents.

Authors:  Marvin J Meyers; Elizabeth J Anderson; Sarah A McNitt; Thomas M Krenning; Megh Singh; Jing Xu; Wentian Zeng; Limei Qin; Wanwan Xu; Siting Zhao; Li Qin; Christopher S Eickhoff; Jonathan Oliva; Mary A Campbell; Stacy D Arnett; Michael J Prinsen; David W Griggs; Peter G Ruminski; Daniel E Goldberg; Ke Ding; Xiaorong Liu; Zhengchao Tu; Micky D Tortorella; Francis M Sverdrup; Xiaoping Chen
Journal:  Bioorg Med Chem       Date:  2015-03-04       Impact factor: 3.641

7.  Molecular shape and medicinal chemistry: a perspective.

Authors:  Anthony Nicholls; Georgia B McGaughey; Robert P Sheridan; Andrew C Good; Gregory Warren; Magali Mathieu; Steven W Muchmore; Scott P Brown; J Andrew Grant; James A Haigh; Neysa Nevins; Ajay N Jain; Brian Kelley
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

Review 8.  The "Sticky Patch" Model of Crystallization and Modification of Proteins for Enhanced Crystallizability.

Authors:  Zygmunt S Derewenda; Adam Godzik
Journal:  Methods Mol Biol       Date:  2017

Review 9.  BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease.

Authors:  Arun K Ghosh; Heather L Osswald
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

10.  Exploring the binding of BACE-1 inhibitors using comparative binding energy analysis (COMBINE).

Authors:  Shu Liu; Rao Fu; Xiao Cheng; Sheng-Ping Chen; Li-Hua Zhou
Journal:  BMC Struct Biol       Date:  2012-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.